Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MNCs for Optic Nerve Disease
NCT01834079Phase 2Unknown
- Sponsor
- Chaitanya Hospital
- Start
- Sep 2014
- Primary completion
- Jul 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in Optic neuropathy, optic atrophy, sponsored by Chaitanya Hospital. Status: unknown.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
Optic neuropathyoptic atrophy
Beyond the preview
Go deeper on NCT01834079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01834079.